P. Dupont

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network.

A. Péchinot, J. Croizé, M. Kempf, 2011, Microbial drug resistance.

Antimicrobial resistance data on 16,756 Streptococcus pneumoniae isolates in 1999: A Pan-Regional Multicenter Surveillance Study in France.

A. Péchinot, J. Cottin, H. Chardon, 2005, Microbial drug resistance.

Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.

D. Hocquet, P. Plésiat, K. Jeannot, 2005, The Journal of antimicrobial chemotherapy.

Contribution of the ATP Binding Site of ParE to Susceptibility to Novobiocin and Quinolones in Streptococcus pneumoniae

L. Gutmann, A. Aubry, E. Cambau, 2005, Journal of bacteriology.

Evaluation of hypoxia in an experimental rat tumour model by [18F]Fluoromisonidazole PET and immunohistochemistry

L. Dubois, P. Dupont, L. Mortelmans, 2004, British Journal of Cancer.